Association of the Use of Novel Antihyperglycaemic Drugs With Prevention of COPD Exacerbations Among Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
BMJ 2022 Nov 01;379(xx)e071380, R Pradhan, S Lu, H Yin, OHY Yu, P Ernst, S Suissa, L AzoulayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.